2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Staphylococcus Aureus Endocarditis: new trials by email Literature Review of Staphylococcus Aureus Endocarditis trials Research Report on Staphylococcus Aureus Endocarditis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus Rifampin, No rifampin - Staphylococcus Aureus Endocarditis, Prosthetic Valve Endocarditis | Phase 3 | Terminated | Todd C. Lee MD MPH FIDSA | 1 | 2025-11-10 | 2026-09-21 |
| Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase Exebacase, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis | Phase 3 | Terminated | ContraFect | 259 | 2019-12-20 | 2023-11-02 |
ContraFect (1) · Todd C. Lee MD MPH FIDSA (1)
Canada (1) · United States (1)
2025 (1)